Citigroup’s Tonix Pharmaceuticals TNXP Stock Holding History

Citigroup’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$39.8K	Buy	2,898 +2,557	+750%	+$39.4K	﹤0.01%	4612
2025 Q4	$5.33K	Buy	341 +92	+37%	+$1.7K	﹤0.01%	5226
2025 Q3	$6.02K	Sell	249 -2,290	-90%	-$85K	﹤0.01%	5181
2025 Q2	$91.4K	Buy	2,539 +2,417	+1,981%	+$63.3K	﹤0.01%	4449
2025 Q1	$2.18K	Buy	+122	New	+$2.47K	﹤0.01%	5340
2023 Q3	–	Hold	0	–	-$24	–	5808
2023 Q2	–	Hold	0	–	–	–	5493
2022 Q4	–	Hold	0	–	–	–	5957
2022 Q3	–	Hold	0	–	–	–	6320
2022 Q2	–	Hold	0	–	–	–	5338
2022 Q1	–	Hold	0	–	–	–	5122
2021 Q4	–	Hold	0	–	–	–	5108
2021 Q3	–	Hold	0	–	–	–	5074
2021 Q2	–	Hold	0	–	–	–	5402
2021 Q1	–	Hold	0	–	–	–	7359
2020 Q4	–	Hold	0	–	–	–	7627
2020 Q3	–	Hold	0	–	–	–	7603
2020 Q2	–	Hold	0	–	–	–	7676
2020 Q1	–	Hold	0	–	–	–	7777
2019 Q4	–	Hold	0	–	–	–	7804
2019 Q3	–	Hold	0	–	–	–	7633
2019 Q1	–	Hold	0	–	-$34K	–	7809
2018 Q4	–	Hold	0	–	–	–	6541
2016 Q2	–	Hold	0	–	–	–	7437
2016 Q1	–	Hold	0	–	–	–	7763
2015 Q4	–	Hold	0	–	–	–	7417
2015 Q3	–	Hold	0	–	-$1K	–	7714
2015 Q2	–	Hold	0	–	–	–	7338
2015 Q1	–	Hold	0	–	-$1K	–	7432
2014 Q4	–	Hold	0	–	–	–	6995
2014 Q3	–	Hold	0	–	–	–	5890
2014 Q1	–	Hold	0	–	-$1K	–	7206
2013 Q4	–	Hold	0	–	–	–	6880

Other funds holding TNXP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citigroup's TNXP Position: Q1 2026 in Review

Citigroup increased its Tonix Pharmaceuticals (TNXP) stake by 750% in Q1 2026, buying an estimated $39.4K and bringing the position to 2,898 shares worth $39.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4612.

Citigroup first reported a position in TNXP in Q1 2025 and has held it in 5 quarters since. The position peaked at $91.4K in Q2 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

Citigroup held 2,898 shares of Tonix Pharmaceuticals worth $39.8K as of Q1 2026.
Citigroup bought 2,557 Tonix Pharmaceuticals shares in Q1 2026, an estimated $39.4K.
Tonix Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4612 holding.
Citigroup first reported a position in Tonix Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
Citigroup's Tonix Pharmaceuticals position peaked at $91.4K in Q2 2025.
81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.